Additional Coverage:
- FDA recalls more than 7,000 bottles of antidepressant over a possible cancerous chemical (newsbreak.com)
Antidepressant Recall Due to Cancer Risk
The Food and Drug Administration (FDA) has recalled over 7,000 bottles of the antidepressant Cymbalta due to the presence of a chemical impurity called nitrosamine. This impurity has been linked to an increased risk of cancer.
Affected Medication
The recall affects bottles of Cymbalta 500mg delayed-release capsules with lot number 220128, expiring in December 2024.
What to Do if Affected
Individuals with the affected medication should stop taking it and consult their healthcare provider for alternative treatment options.
Nitrosamines
Nitrosamines are chemicals found in various foods and products, including water, cured meats, and vegetables. Long-term exposure to high levels of nitrosamines has been associated with an increased risk of cancer.
Previous Recalls
Other medications, including blood pressure-lowering drugs, heartburn treatments, and diabetes medications, have been recalled in the past due to nitrosamine contamination.